Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-11-01
1979-09-11
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424324, 424286, 424300, 260465D, A61K 31275, A61K 31165, C07C12150, C07C12160
Patent
active
041675819
ABSTRACT:
1-Aryloxy-3-aminoalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess .beta.-adrenergic blocking activity and some of them additionally possess cardiac stimulant activity. Representative of the compounds disclosed is 1-(2-cyanophenoxy)-3-.beta.(4-hydroxyphenylacetamido)ethylamino-2-propanol .
REFERENCES:
patent: 3459782 (1969-08-01), Koppe et al.
patent: 3663607 (1972-05-01), Barrett et al.
patent: 3712927 (1973-01-01), Howe et al.
patent: 3732277 (1973-05-01), Koppe et al.
patent: 3933911 (1976-01-01), Main
patent: 3961072 (1976-06-01), Cox et al.
patent: 4010189 (1977-03-01), Smith
patent: 4034106 (1977-07-01), Smith
patent: 4041075 (1977-08-01), Smith
Imperial Chemical Industries Limited
Meyers Albert T.
Robinson D. W.
LandOfFree
Alkanolamine derivatives and pharmaceutical compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkanolamine derivatives and pharmaceutical compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanolamine derivatives and pharmaceutical compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-478162